AsclepiX Therapeutics is a biopharmaceutical company which focuses on therapies based on a peptide platform. It offers the treatment of retinal disease and cancer. The Company also develops its treatment for diabetic macular edema (DME) and wet age-related macular degeneration (wet AMD).